FDA Drug Safety Communication, page-20

If you think about it rationally, the announcement / call were the best case scenario!

The FDA were never going to unilaterally declare Axiron safe and reduce the risk warnings: to do so would expose them to potential litigation and so the best case was what happened.

The recent results were as expected, it is just that expectations were awry, due to poor research or knowledge of the company.

We're in seeming freefall and despair......isn't that the time to start thinking about making money? - It's a buy now.